No Publication. Neither party may publicize or disclose to any third party, without the written consent of the other party, the terms of this Agreement. Without limiting the generality of the foregoing sentence, no press releases may be made without the mutual written consent of each party.
No Publication. XTL shall not publish or publicly present any information (a) relating to this Agreement, (b) any activities conducted under or in relation to this Agreement, or (c) relating to any Product, in all cases without the prior written consent of CUBIST. Neither Party shall make public use of the other Party’s name or identifying marks except as otherwise permitted under this Agreement, with the prior written consent of the other Party or as required by applicable law or regulation. CUBIST shall not use the names of Yeda, the Weizmann Institute of Science, Rehovot, or Xxxxxxxxx Xxxx Xxxxxxx in any advertising, sales literature, or promotional material unless (i) the prior written approval of Yeda thereto has been obtained or (ii) such use or disclosure is to governmental authorities for the purposes of obtaining approval or permission for the exercise of its license rights to any XTL Technology licensed to XTL pursuant to the XY Agreement or is in the fulfillment of any legal duty owed to any governmental authority or is required by applicable law. Nothing in this Section 8.3 shall limit XTL’s ability to apply for any patent protection.
No Publication. Except as, and only to the extent, otherwise expressly provided in Sections 2.2 and 5.2, Licensee shall not publish, disseminate or otherwise disclose or make available Confidential Information or Highly Confidential Information received hereunder to any person, firm or corporation without prior written consent of Licensor.
No Publication. Neither Party shall disclose, publicize or advertise in any manner the discussions or negotiations contemplated by this Agreement or any other Confidential Information without the prior written consent of the other Party, except as may be required by applicable law or regulation or by any competent judicial, governmental, supervisory or regulatory body (including without limitation, any stock exchange).
No Publication. The Parties' acknowledge Xxxx's interest in obtaining valid patent protection and in protecting business interests and patentable information. Consequently, VEGAMOUR shall not publicize or disclose to any third party any research results (including raw and summarized), documentation, accounts, notes, data, formulations, analyses, information, records, or reports, and other information or data that is generated under this Agreement (the “Results”), without the written consent of Bolt, which will not be unreasonably withheld or delayed. A publication includes, but is not limited to, academic, scientific, medical, marketing, patent, or other publication or presentation that contains or refers to information related to the bSilk protein, bSilk Powder, or Results generated under this Agreement. Without limiting the generality of the foregoing, no press releases may be made without the mutual written consent of each Party.
No Publication. 14.13 Severability.................................................. *Material has been omitted pursuant to a request for confidential treatment. Such material has been filed separately with the Securities and Exchange Commission. CONFIDENTIAL
No Publication. Contractor will not make any press releases, public statements, or advertisement referring to this Agreement, or release any information relative to this Agreement or any Work authorized under this Agreement for publication, advertisement or any other purpose, without the prior written approval of the Owner.
No Publication. Neither party may publicize or disclose the terms of this Agreement to any third party without the written consent of the other Party. Without limiting the generality of the foregoing sentence, no press releases may be made without the mutual written consent of the Parties. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
No Publication. Neither party shall have the authority to make any statement, representation or commitment of any kind, or to take any action, which shall be binding on the other, without the prior consent of the other party. “Receiving Party” may not issue any press release or other publication with respect of the services and/or works provided to the “Disclosing Party”, without the “Disclosing Party” prior written consent.
No Publication. Recipient shall not use Duke’s name or the fact that Recipient has entered into this Agreement with Xxxx or received any funds hereunder from Duke in any press releases, media statements or public communications or otherwise publicize the existence or content of this Agreement without Duke’s prior written consent. Recipient shall not use Duke’s (including its subsidiaries and affiliates) name, logos, copyrights, trademarks, service marks, trade names or trade secrets in any way without Duke’s prior written consent, and Duke shall not be deemed to have granted Recipient a license of, or granted Recipient any rights in, any of the foregoing by entering into this Agreement.
